Next Article in Journal
Zeb2 DNA-Binding Sites in Neuroprogenitor Cells Reveal Autoregulation and Affirm Neurodevelopmental Defects, Including in Mowat-Wilson Syndrome
Previous Article in Journal
Deep Learning-Based Feature Extraction with MRI Data in Neuroimaging Genetics for Alzheimer’s Disease
Previous Article in Special Issue
Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of a Less Invasive Cochlear Implant Surgery in OPA1 Mutations Provoking Deafblindness

1
Department of Otorhinolaryngology Head and Neck Surgery, University Hospital UZ Brussel, Vrije Universiteit Brussel, Brussels Health Campus, 1090 Brussels, Belgium
2
Department of Otolaryngology Head and Neck Surgery, Medipol University Hospital, University of Medipol, Istanbul 34214, Turkey
3
Department of Otorhinolaryngology, Head and Neck Surgery, Antwerp University Hospital, 2650 Edegem, Belgium
4
Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium
*
Author to whom correspondence should be addressed.
Genes 2023, 14(3), 627; https://doi.org/10.3390/genes14030627
Submission received: 10 December 2022 / Revised: 10 February 2023 / Accepted: 27 February 2023 / Published: 2 March 2023
(This article belongs to the Special Issue Functional Otogenetics)

Abstract

Cochlear implantation (CI) for deafblindness may have more impact than for non-syndromic hearing loss. Deafblind patients have a double handicap in a society that is more and more empowered by fast communication. CI is a remedy for deafness, but requires revision surgery every 20 to 25 years, and thus placement should be minimally invasive. Furthermore, failed reimplantation surgery will have more impact on a deafblind person. In this context, we assessed the safety of minimally invasive robotically assisted cochlear implant surgery (RACIS) for the first time in a deafblind patient. Standard pure tone audiometry and speech audiometry were performed in a patient with deafblindness as part of this robotic-assisted CI study before and after surgery. This patient, with an optic atrophy 1 (OPA1) (OMIM#165500) mutation consented to RACIS for the second (contralateral) CI. The applicability and safety of RACIS were evaluated as well as her subjective opinion on her disability. RACIS was uneventful with successful surgical and auditory outcomes in this case of deafblindness due to the OPA1 mutation. RACIS appears to be a safe and beneficial intervention to increase communication skills in the cases of deafblindness due to an OPA1 mutation. The use of RACIS use should be widespread in deafblindness as it minimizes surgical trauma and possible failures.
Keywords: sensorineural hearing loss; otogenetics; genetic deafness; hereditary hearing impairment; deafblindness; genetic analyses on sensorineural hearing loss; image guided surgery; robot assisted cochlear implantation surgery sensorineural hearing loss; otogenetics; genetic deafness; hereditary hearing impairment; deafblindness; genetic analyses on sensorineural hearing loss; image guided surgery; robot assisted cochlear implantation surgery

Share and Cite

MDPI and ACS Style

Tekin, A.M.; Baelen, H.; Heuninck, E.; Bayazıt, Y.A.; Mertens, G.; Rompaey, V.v.; Heyning, P.v.d.; Topsakal, V. Evaluation of a Less Invasive Cochlear Implant Surgery in OPA1 Mutations Provoking Deafblindness. Genes 2023, 14, 627. https://doi.org/10.3390/genes14030627

AMA Style

Tekin AM, Baelen H, Heuninck E, Bayazıt YA, Mertens G, Rompaey Vv, Heyning Pvd, Topsakal V. Evaluation of a Less Invasive Cochlear Implant Surgery in OPA1 Mutations Provoking Deafblindness. Genes. 2023; 14(3):627. https://doi.org/10.3390/genes14030627

Chicago/Turabian Style

Tekin, Ahmet M., Hermine Baelen, Emilie Heuninck, Yıldırım A. Bayazıt, Griet Mertens, Vincent van Rompaey, Paul van de Heyning, and Vedat Topsakal. 2023. "Evaluation of a Less Invasive Cochlear Implant Surgery in OPA1 Mutations Provoking Deafblindness" Genes 14, no. 3: 627. https://doi.org/10.3390/genes14030627

APA Style

Tekin, A. M., Baelen, H., Heuninck, E., Bayazıt, Y. A., Mertens, G., Rompaey, V. v., Heyning, P. v. d., & Topsakal, V. (2023). Evaluation of a Less Invasive Cochlear Implant Surgery in OPA1 Mutations Provoking Deafblindness. Genes, 14(3), 627. https://doi.org/10.3390/genes14030627

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop